Learn about the effectiveness and adverse effects of approved bipolar depression treatments and discover areas for future study.
Find out about adjustments in both psychotherapy and pharmacotherapy for patients with OCD and comorbid depression, bipolar disorder, schizophrenia, or eating disorders.
Review ways to assess and address barriers to adherence and to monitor side effects that contribute to nonadherence and dangerous health conditions.
Schizophrenia: Mechanism of Action of Current and Novel Treatments
New! Review the mechanism of action of available antipsychotics, learn why they're not effective for treating all symptoms, and find out about a potential treatment target.
Do you treat your patients with MDD until they are asymptomatic? Read this CME Supplement to find out how to recognize, monitor, and treat residual symptoms.
Two-thirds of patients with bipolar disorder relapsed during a 4-year, naturalistic follow-up. Explore this and other findings in this CME article.
Learn how vision problems and cognitive decline may be indicative of a variant of Alzheimer's disease.
Get an overview of core themes in troubled relationships as well as ways to assess for, prevent, and address intimate partner violence in veterans and their families.
Discover which disorders are often confused with restless legs syndrome (RLS) and which conditions and medications are associated with secondary RLS.
New! Learn how to use rating scales to track efficacy and discover ways to monitor common side effects.
Find out how to differentiate and treat the cause of negative symptoms and to recognize symptoms of apathy and diminished expression.
Review the burden of and risk factors for TRD, learn how to assess for treatment resistance, and find out about current and new therapeutic strategies.
Measurement-Based Strategies to Assess and Manage Schizophrenia
New! Discover how to distinguish between primary and secondary negative symptoms, find out how to assess treatment response, and review new therapeutic targets.
Strategies for Achieving Full Remission
Discover how to assess problems with first-line treatment and implement the best second-line treatment option to help your patients achieve asympomatic remission.
Please take our online poll
Science, Rhetoric, and the End of Psychosis
Dr Amos voices his concerns about bias in the early intervention in psychosis literature. He welcomes your comments.